Granicip – Granisetron 1 DT Tablet
Description
Granisetron (Granicip) Tablet – Treatment for Cancer Therapy
Granicip 1 DT Tablet is an antiemetic medication that is widely used to treat nausea and vomiting induced by surgery, cancer treatment therapy, or radiation.
Granicip 1 DT Tablet is intended to reduce nausea and vomiting induced by certain medications or cancer therapy. It inhibits the function of substances in the body that might cause you to feel or get ill. This medication helps you recover from cancer treatments including radiation therapy or chemotherapy.
Other negative effects connected with cancer therapies will not be alleviated by Granicip 1 DT Tablet. It also has minimal impact on motion sickness-induced vomiting. You should take this medication according to your doctor’s instructions on the dosage and duration. However, it is preferable to take this medication at a predetermined time. Remember, you should not stop taking this medication abruptly without first consulting with your doctor. If you vomit within an hour after taking a dosage, take another dose and avoid large meals for the rest of the day.
Fedelty Health Care is a certified Granisetron Bulk Pharma Exporter, Cargo Bulk Supplier, and pharmaceutical wholesaler in India.
USES OF GRANISETRON (GRANICIP) 1 DT TABLET
- Nausea and vomiting due to chemotherapy
WORKS OF GRANISETRON (GRANICIP) 1 DT TABLET
Granicip 1 DT Tablet works as an antiemetic. It works by inhibiting the function of a chemical messenger (serotonin) in the brain, which can induce nausea and vomiting during cancer treatment (chemotherapy) or after surgery.
DIRECTIONS FOR USE:
Take this medication exactly as directed by your doctor, for the duration and at the dose advised. Dissolve it in a glass of water before taking it. Granicip 1 DT Tablet can be taken with or without meals, although it is best to take it at the same time every day.
Fedelty Health Care is a certified Granisetron Bulk Pharma Exporter, Cargo Bulk Supplier, and pharmaceutical wholesaler in India.
SIDE EFFECTS OF GRANISETRON (GRANICIP) 1 DT TABLET
- Weakness
- Headache
- Constipation
- Diarrhea
- Insomnia (difficulty in sleeping)
WARNING & PRECAUTIONS
- Driving
Granicip 1 DT Tablet normally has no effect on your ability to drive.
- Kidney
Granicip 1 DT Tablet is probably safe to use in renal disease patients. Based on the current data, it appears that no dosage change of Granicip 1 DT Tablet is required in these individuals. Please visit your physician.
- Liver
Granicip 1 DT Tablet is most likely safe for individuals with liver problems to take. Based on the current data, it appears that no dosage change of Granicip 1 DT Tablet is required in these individuals. Please visit your physician.
- Pregnancy
Granicip 1 DT Tablet is generally thought to be safe to take during pregnancy. Animal research has revealed that there are few or no negative effects on the growing fetus; nevertheless, human studies are few.
- Breastfeeding
Granicip 1 DT Tablet is most likely safe to use during nursing. According to the limited human evidence, the medication poses no major harm to the fetus.
Fedelty Health Care is a Granisetron third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.
